OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Male-specific bacteriophages and their potential on combating the spreading of T4SS-bearing antimicrobial resistance plasmids	137
Neuroinflammation-mediated relationship between oral microbiome and neurodegenerative diseases	99
Dynamics of antibiotic resistance genes in plasmids and bacteriophages	73
Salmonella in eggs and egg-laying chickens: pathways to effective control	66
TREM-2: friend or foe in infectious diseases?	62
Helicobacter pylori infection: from standard to alternative treatment strategies	54
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	50
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19	41
Paving the way forward: Escherichia coli bacteriophages in a One Health approach	41
Host and bacterial lipid metabolism during tuberculosis infections: possibilities to synergise host- and bacteria-directed therapies	40
Engineered probiotics as live biotherapeutics for diagnosis and treatment of human diseases	39
Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens	39
Targeting bioinformatics tools to study the dissemination and spread of antibiotic resistant genes in the environment and clinical settings	34
Biosynthesis, regulation, and biological significance of fumonisins in fungi: current status and prospects	34
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	33
Outer membrane proteins and vesicles as promising vaccine candidates against Vibrio spp. infections	31
Exploring halophilic environments as a source of new antibiotics	30
Bile acid–gut microbiota crosstalk in irritable bowel syndrome	30
LysR-type transcriptional regulators: state of the art	29
Applications of bacteriophages against intracellular bacteria	29
Interplay between Clostridioides difficile infection, host immunity, and metabolism: a comprehensive review	27
Vibrio cholerae virulence and its suppression through the quorum-sensing system	27
Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge	26
Emerging cellular and molecular interactions between the lung microbiota and lung diseases	25
The microbiome and precision oncology: an emerging paradigm in anticancer therapy	25

The role of influenza A virus-induced hypercytokinemia	24
Advances in the applications of Bacteriophages and phage products against food-contaminating bacteria	24
The diffusible signaling factor family in microbial signaling: a current perspective	22
The role of single and mixed biofilms in Clostridioides difficile infection and strategies for prevention and inhibition	22
Polyamine as a microenvironment factor in resistance to antibiotics	22
Bdellovibrio bacteriovorus: a potential ‘living antibiotic’ to control bacterial pathogens	21
Building up a clinical microbiota profiling: a quality framework proposal	21
Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness	21
Antibiotic resistance in Pseudomonas aeruginosa : mechanisms and emerging treatment	20
Phage-bacterial evolutionary interactions: experimental models and complications	20
Emerging strategies to target virulence in Pseudomonas aeruginosa respiratory infections	20
Emergence of persister cells in Staphylococcus aureus : calculated or fortuitous move?	19
Burkholderia in the genomic era: from taxonomy to the discovery of new antimicrobial secondary metabolites	18
Microbial persisters and host: recent advances and future perspectives	18
Microbial biosynthesis of nucleos(t)ide analogs: applications, and engineering optimization	18
Multidrug-resistantTrichosporonspecies: underestimated fungal pathogens posing imminent threats in clinical settings	17
Quorum sensing in biofilms: a key mechanism to target in ecotoxicological studies	17
Ureaplasma infections: update on epidemiology, antimicrobial resistance, and pathogenesis	17
Current types of staphylococcal cassette chromosome mec (SCC mec ) in clinically relevant coagulase-negative staphylococcal (CoNS) species	16
Porphyromonas gingivalis and the pathogenesis of Alzheimer’s disease	15
Ocular surface microbiota dysbiosis contributes to the high prevalence of dry eye disease in diabetic patients	15
Advances in mining and expressing microbial biosynthetic gene clusters	15
Nanophotocatalysts against viruses and antibiotic-resistant bacteria: recent advances	15
Bacillusspore-forming probiotics: benefits with concerns?	15
Review on computer-assisted biosynthetic capacities elucidation to assess metabolic interactions and communication within microbial communities	14
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	14
Aspergilli series Versicolores: importance of species identification in the clinical setting	13
The crosstalk between SUMOylation and immune system in host-pathogen interactions	13
Insights into the molecular basis of c-di-GMP signalling in Pseudomonas aeruginosa	13
Community dynamics of subgingival microbiome in periodontitis and targets for microbiome modulation therapy	13
The potential for bacteriophages and prophage elements in fighting and preventing the gonorrhea	13